Deal date

KANDO id: 717922

Financial Transaction:

Series A


New Haven Pharmaceuticals Inc



Round participants

Country Notes

Advantage Capital Partners

Investment firm focused on businesses located in states and communities that are underserved by traditional sources of risk capital.
United States Initial investment.

Connecticut Innovations Inc

(CI)
United States Initial investment.